Skip to main content
Retour
Watch Compare

Yubo International Biotech Ltd

Qualité des données : 100%
YBGJ
OTC Manufacturing Measuring & Analyzing Instruments
0,01 €
0,00 € (0,00%)
Cap. Boursière: 1,62 M
Prix
0,01 €
Cap. Boursière
1,62 M
Fourchette du Jour
0,01 € — 0,01 €
Fourchette 52 Semaines
0,01 € — 0,18 €
Volume
10 000
Ouverture 0,01 €
Moyenne 50J / 200J
0,01 €
24,00% below
Moyenne 50J / 200J
0,02 €
58,33% below

Quick Summary

Points Clés

Negative free cash flow of -842 802,0

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)255,99%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net Margin-8736,73%
Op. Margin-9614,64%

Sécurité

Debt / Equity
N/A
Current Ratio0,25
Interest CoverageN/A

Valorisation

PE (TTM)
-1,50
En dessous de la moyenne du secteur (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -1,5 -1,5
P/B — 1,6
ROE % — -53,4
Net Margin % -8736,7 -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 255,99% Revenue Growth (3Y) -85,71%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 12 353,0 Net Income (TTM) -1,08 M
ROE N/A ROA -107,67%
Gross Margin 66,10% Operating Margin -9614,64%
Net Margin -8736,73% Free Cash Flow (TTM) -842 802,0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,25
Interest Coverage N/A Asset Turnover 0,01
Working Capital -1,91 M Tangible Book Value -1,71 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,50 Forward P/E N/A
P/B Ratio N/A P/S Ratio 131,06
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -52,06%
Market Cap 1,62 M Enterprise Value 1,61 M
Per Share
EPS (Diluted TTM) -0,01 Revenue / Share 0,00
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 78,09%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 12 353,0 3 470,0 604 676,0 104 283,0 —
Net Income -1,08 M -1,98 M -1,20 M -1,20 M -1,54 M
EPS (Diluted) -0,01 -0,02 — — —
Gross Profit 8 165,0 2 648,0 419 185,0 52 652,0 820 647,0
Operating Income -1,19 M -1,77 M -1,19 M -1,21 M -1,54 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A 167 581,0 169 875,0 178 312,0 18 098,0 21 401,0
Interest Expense — 50,0 -377,0 229,0 427,0
Income Tax 0,0 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 847 094,0 1,53 M 1,67 M 2,35 M 4,59 M
Total Liabilities 2,79 M 4,83 M 3,51 M 2,91 M 4,72 M
Shareholders' Equity -1,95 M -3,42 M -1,84 M -565 373,0 -131 198,0
Total Debt — — — — —
Cash & Equivalents 8 062,0 7 015,0 6 359,0 18 220,0 27 517,0
Current Assets 667 512,0 682 751,0 725 235,0 750 012,0 1,06 M
Current Liabilities 2,79 M 4,72 M 3,40 M 2,52 M 2,79 M